PL337723A1 - Inhalable tocopherol-stabilised prolyposomic powders - Google Patents

Inhalable tocopherol-stabilised prolyposomic powders

Info

Publication number
PL337723A1
PL337723A1 PL98337723A PL33772398A PL337723A1 PL 337723 A1 PL337723 A1 PL 337723A1 PL 98337723 A PL98337723 A PL 98337723A PL 33772398 A PL33772398 A PL 33772398A PL 337723 A1 PL337723 A1 PL 337723A1
Authority
PL
Poland
Prior art keywords
prolyposomic
inhalable
stabilised
tocopherol
powders
Prior art date
Application number
PL98337723A
Other languages
English (en)
Inventor
Katarina Bystroem
Per-Gunnar Nilsson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PL337723A1 publication Critical patent/PL337723A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL98337723A 1997-06-27 1998-06-08 Inhalable tocopherol-stabilised prolyposomic powders PL337723A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88441997A 1997-06-27 1997-06-27
PCT/SE1998/001090 WO1999000111A1 (en) 1997-06-27 1998-06-08 Proliposome powders for inhalation stabilised by tocopherol

Publications (1)

Publication Number Publication Date
PL337723A1 true PL337723A1 (en) 2000-08-28

Family

ID=25384589

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98337723A PL337723A1 (en) 1997-06-27 1998-06-08 Inhalable tocopherol-stabilised prolyposomic powders

Country Status (18)

Country Link
EP (1) EP1001749A1 (id)
JP (1) JP2002510311A (id)
KR (1) KR20010014163A (id)
CN (1) CN1260713A (id)
AU (1) AU729100B2 (id)
BR (1) BR9810280A (id)
CA (1) CA2295028A1 (id)
EE (1) EE9900601A (id)
HU (1) HUP0003207A3 (id)
ID (1) ID23192A (id)
IL (1) IL133478A0 (id)
IS (1) IS5304A (id)
NO (1) NO996439L (id)
NZ (1) NZ501672A (id)
PL (1) PL337723A1 (id)
SK (1) SK184899A3 (id)
TR (1) TR199903271T2 (id)
WO (1) WO1999000111A1 (id)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1138311A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
EP1138310A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
EP1138313A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
PL1888033T3 (pl) * 2005-06-09 2014-09-30 Meda Ab Sposób i kompozycja do leczenia chorób zapalnych
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
JP6458322B2 (ja) * 2013-05-06 2019-01-30 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． 粉末状ビタミンｅ製剤
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CN105078963B (zh) * 2015-09-29 2018-06-22 中山大学 α-生育酚在制备治疗血吸虫病药物中的应用
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
WO2020018974A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081474A1 (en) * 1990-05-08 1991-11-09 Manzer Durrani Direct spray-dried drug/lipid powder composition
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.

Also Published As

Publication number Publication date
SK184899A3 (en) 2000-05-16
KR20010014163A (ko) 2001-02-26
CN1260713A (zh) 2000-07-19
CA2295028A1 (en) 1999-01-07
EP1001749A1 (en) 2000-05-24
NZ501672A (en) 2001-06-29
AU7945698A (en) 1999-01-19
TR199903271T2 (en) 2000-08-21
NO996439D0 (no) 1999-12-23
BR9810280A (pt) 2000-09-12
IL133478A0 (en) 2001-04-30
JP2002510311A (ja) 2002-04-02
AU729100B2 (en) 2001-01-25
HUP0003207A2 (hu) 2001-02-28
NO996439L (no) 2000-02-28
IS5304A (is) 1999-12-15
EE9900601A (et) 2000-08-15
ID23192A (id) 2000-03-23
WO1999000111A1 (en) 1999-01-07
HUP0003207A3 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
US5797392C1 (en) Inhaler
GB9626263D0 (en) Powder inhaler
PL334447A1 (en) Inhaler
PL335799A1 (en) Inhaler
AU135548S (en) Inhaler
PL335690A1 (en) Inhaler
PL335701A1 (en) Inhaler
AU135120S (en) Inhaler
AU5889398A (en) Powder inhaler
GB2318737B (en) Improved inhalers
HUP0001799A3 (en) Dry powder inhaler
PL327616A1 (en) Inhaler
HUP9901316A3 (en) Inhaler
IL141821A0 (en) Inhaler
AU135340S (en) An inhaler
IL116459A0 (en) Powder formulations
ZA976137B (en) Powder atomizer
GB2312379B (en) Improved inhalers
GB9826783D0 (en) Inhalation powders
PL337723A1 (en) Inhalable tocopherol-stabilised prolyposomic powders
EP1026124A4 (en) COMPOSITE POWDER
GB2320900B (en) Inhalers
GB2310370B (en) Inhaler carrying aid
EP1044161A4 (en) FESTSTOFFTEILCHENHERTSELLUNG
GB2329582B (en) Powder Puff